NOL10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.778800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.247200E-01
Normal-vs-Stage2
2.757600E-01
Normal-vs-Stage3
8.224600E-01
Normal-vs-Stage4
2.197900E-02
Stage1-vs-Stage2
8.240200E-01
Stage1-vs-Stage3
2.506400E-01
Stage1-vs-Stage4
1.868590E-01
Stage2-vs-Stage3
1.254630E-01
Stage2-vs-Stage4
3.848300E-02
Stage3-vs-Stage4
3.211600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.784400E-01
Normal-vs-AfricanAmerican
3.303000E-01
Normal-vs-Asian
3.514000E-01
Caucasian-vs-AfricanAmerican
6.000400E-01
Caucasian-vs-Asian
1.089970E-01
AfricanAmerican-vs-Asian
3.979400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.000600E-01
Normal-vs-Female
2.621400E-01
Male-vs-Female
9.150800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.641400E-01
Normal-vs-Age(41-60Yrs)
1.293970E-01
Normal-vs-Age(61-80Yrs)
4.074000E-01
Normal-vs-Age(81-100Yrs)
1.288160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.094800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.346200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.143000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.053700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.216000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.514200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.977400E-01
Normal-vs-Daily Drinker
4.410400E-01
Normal-vs-Weekly Drinker
3.427800E-01
Normal-vs-Occasional Drinker
5.197900E-02
Normal-vs-Social Drinker
1.618840E-01
Non Drinker-vs-Daily Drinker
5.911800E-01
Non Drinker-vs-Weekly Drinker
4.405000E-01
Non Drinker-vs-Occasional Drinker
8.400400E-02
Non Drinker-vs-Social Drinker
3.350200E-01
Daily Drinker-vs-Weekly Drinker
8.163400E-01
Daily Drinker-vs-Occasional Drinker
3.307600E-01
Daily Drinker-vs-Social Drinker
7.410800E-01
Weekly Drinker-vs-Occasional Drinker
5.247800E-01
Weekly Drinker-vs-Social Drinker
9.472400E-01
Occasional Drinker-vs-Social Drinker
4.782400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.545200E-01
Normal-vs-Grade 2
7.335000E-01
Normal-vs-Grade 3
6.505400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.000100E-02
Grade 1-vs-Grade 3
2.418700E-03
Grade 1-vs-Grade 4
8.545200E-01
Grade 2-vs-Grade 3
7.771800E-02
Grade 2-vs-Grade 4
7.335000E-01
Grade 3-vs-Grade 4
6.505400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.446600E-01
Normal-vs-NonDiabetic
2.568000E-01
Diabetic-vs-NonDiabetic
7.180600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.502000E-01
Normal-vs-NoPancreatitis
3.159000E-01
Pancreatitis-vs-NoPancreatitis
5.350400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.992840E-01
Normal-vs-N1
2.793200E-01
N0-vs-N1
8.350400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.184900E-04
Normal-vs-TP53-NonMutant
4.884000E-02
TP53-Mutant-vs-TP53-NonMutant
1.756350E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
